Inflammatory Markers in Preeclampsia

This study has been completed.
Sponsor:
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01385813
First received: June 29, 2011
Last updated: July 15, 2011
Last verified: May 2011
  Purpose

This is an investigation of inflammatory markers in women destined to develop preeclampsia.


Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Enrollment: 129
Study Start Date: January 1999
Study Completion Date: May 2004
Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)
Groups/Cohorts
Pregnant women who develop preeclampsia
pregnant women who develop preeclampsia (n =43) compared to pregnant women fulfilling a normotensive pregnancy (n= 86).

  Eligibility

Ages Eligible for Study:   20 Years to 43 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The study comprised 43 pregnant women who developed preeclampsia and 86 pregnant women who fulfilled a normotensive pregnancy.

All women were of Caucasian origin, and were nulliparous.

Criteria

Inclusion Criteria:

  • Caucasian origin

Exclusion Criteria:

  • Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Professor Lars Mørkrid, University of Oslo
ClinicalTrials.gov Identifier: NCT01385813     History of Changes
Other Study ID Numbers: INFLAMMARPE11
Study First Received: June 29, 2011
Last Updated: July 15, 2011
Health Authority: Norway: OsloUH

Keywords provided by Oslo University Hospital:
pre-eclampsia
inflammatory markers
serological biobank
To assess whether the inflammatory markers could be useful
in order to identify pregnant women at risk to
develop preeclampsia

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on April 17, 2014